Authors' objectives:

This study aims to assess the current evidence on extracorporeal shockwave therapy for refractory tendinopathies (plantar fasciitis and tennis elbow).

Authors' recommendations: 1.1 Current evidence on extracorporeal shockwave therapy for refractory tendinopathies (specifically tennis elbow and plantar fasciitis) suggests that there are no major safety concerns. Evidence on efficacy is conflicting, and suggests that the procedure produces little benefit apart from a placebo response in some patients. Therefore, current evidence on efficacy does not appear adequate to support its use without special arrangements for consent, and for audit or research. 1.2 Clinicians wishing to undertake extracorporeal shockwave therapy for refractory tendinopathies should take the following actions. - Inform the clinical governance leads in their trusts. - Ensure that patients understand the uncertainty about the procedure's efficacy and provide them with clear written information. In addition, use of the Institute's Information for the public is recommended. - Audit and review clinical outcomes of all patients having extracorporeal shockwave therapy for refractory tendinopathies. The Institute may review the procedure upon publication of further evidence.

Authors' methods: Overview

Project Status: Completed

URL for project: http://www.nice.org.uk/page.aspx?o=279996

Year Published: 2005

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: National Institute for Clinical Excellence

Contact Address: MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801

Contact Name: nice@nice.nhs.uk

Contact Email: nice@nice.nhs.uk

Copyright: National Institute for Clinical Excellence (NICE)